Login / Signup

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.

Roger S McIntyreRoger Nelson RodriguesOrly LipsitzFlora NasriHartej GillLeanna Mw LuiMehala SubramaniapillaiKevin KratiukKayla TeopizRoger HoYena LeeRodrigo B MansurJoshua D Rosenblat
Published in: Journal of psychopharmacology (Oxford, England) (2020)
Patients with TRD and prominent anxiety receiving IV ketamine exhibited a significant reduction in depressive, SI and anxiety symptoms.
Keyphrases
  • bipolar disorder
  • major depressive disorder
  • sleep quality
  • randomized controlled trial
  • systematic review
  • depressive symptoms
  • case report
  • low dose